109 related articles for article (PubMed ID: 16515889)
1. Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein.
Schagen FH; Wensveen FM; Carette JE; Dermody TS; Gerritsen WR; van Beusechem VW
Mol Ther; 2006 May; 13(5):997-1005. PubMed ID: 16515889
[TBL] [Abstract][Full Text] [Related]
2. Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Luongo CL; Komarova S; Kawakami Y; Curiel DT
Biochem Biophys Res Commun; 2005 Sep; 335(1):205-14. PubMed ID: 16061208
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer.
van Beusechem VW; van Rijswijk AL; van Es HH; Haisma HJ; Pinedo HM; Gerritsen WR
Gene Ther; 2000 Nov; 7(22):1940-6. PubMed ID: 11127582
[TBL] [Abstract][Full Text] [Related]
4. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
[TBL] [Abstract][Full Text] [Related]
5. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
6. Generation and selection of targeted adenoviruses embodying optimized vector properties.
Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
[TBL] [Abstract][Full Text] [Related]
7. Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.
Schagen FH; Graat HC; Carette JE; Vellinga J; van Geer MA; Hoeben RC; Dermody TS; van Beusechem VW
Hum Gene Ther; 2008 Aug; 19(8):783-94. PubMed ID: 18627267
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
de Vrij J; Uil TG; van den Hengel SK; Cramer SJ; Koppers-Lalic D; Verweij MC; Wiertz EJ; Vellinga J; Willemsen RA; Hoeben RC
Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790
[TBL] [Abstract][Full Text] [Related]
9. Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber.
Myhre S; Henning P; Friedman M; Ståhl S; Lindholm L; Magnusson MK
Gene Ther; 2009 Feb; 16(2):252-61. PubMed ID: 18946496
[TBL] [Abstract][Full Text] [Related]
10. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
11. Fiber-modified adenoviruses for targeted gene therapy.
Wu H; Curiel DT
Methods Mol Biol; 2008; 434():113-32. PubMed ID: 18470642
[TBL] [Abstract][Full Text] [Related]
12. An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery.
Hedley SJ; Auf der Maur A; Hohn S; Escher D; Barberis A; Glasgow JN; Douglas JT; Korokhov N; Curiel DT
Gene Ther; 2006 Jan; 13(1):88-94. PubMed ID: 16107860
[TBL] [Abstract][Full Text] [Related]
13. Targeting adenovirus.
Wickham TJ
Gene Ther; 2000 Jan; 7(2):110-4. PubMed ID: 10673715
[TBL] [Abstract][Full Text] [Related]
14. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.
Mercier GT; Campbell JA; Chappell JD; Stehle T; Dermody TS; Barry MA
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6188-93. PubMed ID: 15079060
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
Campos SK; Barry MA
Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
[TBL] [Abstract][Full Text] [Related]
16. Genetic targeting strategies for adenovirus.
Noureddini SC; Curiel DT
Mol Pharm; 2005; 2(5):341-7. PubMed ID: 16196486
[TBL] [Abstract][Full Text] [Related]
17. Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency.
Yoshioka Y; Asavatanabodee R; Eto Y; Watanabe H; Morishige T; Yao X; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Life Sci; 2008 Nov; 83(21-22):747-55. PubMed ID: 18930744
[TBL] [Abstract][Full Text] [Related]
18. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.
Tanaka T; Huang J; Hirai S; Kuroki M; Kuroki M; Watanabe N; Tomihara K; Kato K; Hamada H
Clin Cancer Res; 2006 Jun; 12(12):3803-13. PubMed ID: 16778108
[TBL] [Abstract][Full Text] [Related]
20. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
